Leukotriene B4 receptor 2 correlates with prognosis and immune infiltration in clear cell renal cell carcinoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s10637-021-01174-7.pdf
Reference38 articles.
1. Li YL, Wu LW, Zeng LH, Zhang ZY, Wang W (2020) ApoC1 promotes the metastasis of clear cell renal cell carcinoma via activation of STAT3. 39(39):6203–17. https://doi.org/10.1038/s41388-020-01428-3
2. Minton DR, Fu L, Mongan NP, Shevchuk MM, Nanus DM, Gudas LJ (2016) Role of NADH Dehydrogenase (Ubiquinone) 1 Alpha Subcomplex 4-Like 2 in Clear Cell Renal Cell Carcinoma. Clin Cancer Res 22(11):2791–2801. https://doi.org/10.1158/1078-0432.CCR-15-1511
3. Mitchell TJ, Turajlic S, Rowan A, Nicol D, Farmery JHR, O’Brien T et al (2018) Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal. Cell 173(3):611–23.e17. https://doi.org/10.1016/j.cell.2018.02.020
4. Schödel J, Grampp S, Maher ER, Moch H, Ratcliffe PJ, Russo P et al (2016) Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer. Eur Urol 69(4):646–657. https://doi.org/10.1016/j.eururo.2015.08.007
5. Chen M, Zhang S, Nie Z, Wen X, Gao Y (2020) Identification of an Autophagy-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma. Front oncol 10:873. https://doi.org/10.3389/fonc.2020.00873.
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Exploring human CYP4 enzymes: Physiological roles, function in diseases and focus on inhibitors;Drug Discovery Today;2023-05
2. Lipids as Targets for Renal Cell Carcinoma Therapy;International Journal of Molecular Sciences;2023-02-07
3. Screening of Colon Cancer Apoptosis-Related Genes Based on Bioinformatics and Construction of Survival Prognostic Model;Journal of Biosciences and Medicines;2023
4. Fatty acid desaturase 1 (FADS1) is a cancer marker for patient survival and a potential novel target for precision cancer treatment;Frontiers in Oncology;2022-08-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3